Submitted by Anonymous (not verified) on 6 November 2023 - 15:26
Human medicines European public assessment report (EPAR): Imnovid (previously Pomalidomide Celgene), pomalidomide, Multiple Myeloma, Date of authorisation: 05/08/2013, Revision: 24, Status: Authorised
Source: